4.290
4.29 (0%)
As of Dec 20, 2024
Xenetic Biosciences, Inc. [XBIO]
Source:
Company Overview
Xenetic Biosciences, Inc is a biopharmaceutical company focused onadvancing innovative immune-oncology technologies addressing hard to treat cancers. Our DNase platform is designed to improve outcomesof existing treatments, including immunotherapies, by targeting NETs.
Country | United States |
Headquarters | framingham, massachusetts |
Phone Number | 781-778-7720 |
Industry | manufacturing |
CEO | Jeffrey F. Eisenberg |
Website | www.xeneticbio.com |